Schmallenberg Virus

Schmallenberg Virus (SBV) is an emerging enveloped, negative-sense single-stranded RNA virus belonging to the genus Orthobunyavirus within the family Peribunyaviridae. First identified in late 2011 near the town of Schmallenberg in North Rhine-Westphalia, Germany, SBV is transmitted by biting midges of the Culicoides genus, primarily affecting domestic and wild ruminants such as cattle, sheep, and goats. The virus is most notable for causing reproductive failures, including abortions, stillbirths, and severe congenital malformations in newborn offspring, leading to significant economic losses in livestock industries across Europe and beyond. While adult ruminants often exhibit mild or subclinical symptoms, fetal infection during critical gestational stages results in devastating developmental abnormalities. Despite its clinical and economic significance, gaps remain in our understanding of SBV pathogenesis, and no specific antiviral therapies exist, though several vaccines are commercially available in Europe.

Figure 1. Unstanding Schmallenberg Virus.

Virus Classification and Genomic Organisation

SBV is a member of the Simbu serogroup within the genus Orthobunyavirus, family Peribunyaviridae, order Bunyavirales. The virus possesses a tripartite negative-sense, single-stranded RNA genome comprising large (L), medium (M), and small (S) segments, each encapsidated by nucleoprotein (N) to form ribonucleoprotein complexes. The L segment (approximately 6.9 kb) encodes the RNA-dependent RNA polymerase (RdRp), a multifunctional enzyme responsible for viral transcription and genome replication. The M segment (approximately 4.3 kb) encodes a glycoprotein precursor polyprotein that is co-translationally cleaved into two envelope glycoproteins—Gn and Gc—and a non-structural protein designated NSm. Gn and Gc form heterodimeric spikes on the virion surface that mediate receptor binding and membrane fusion during viral entry. The S segment (approximately 0.8 kb) utilises an ambisense coding strategy, encoding the nucleoprotein (N) in the genomic sense and the non-structural protein NSs from an overlapping open reading frame in the antigenomic sense.

Clinical Manifestations and Epidemiology

Acute SBV infection in adult ruminants is often subclinical or manifests as a mild, transient disease characterised by fever, decreased milk production (sometimes dramatic in dairy cattle), diarrhoea, and reduced general condition. These non-specific signs typically resolve within a few days, and most animals recover uneventfully. However, when naive pregnant dams are infected during the susceptible period, the virus crosses the placenta and infects the developing fetus, with tropism for neuronal tissues. Fetal infection results in severe malformations affecting the central nervous system and musculoskeletal system, including arthrogryposis (fixed flexion of joints), torticollis (twisted neck), hydrocephalus, hydranencephaly (replacement of cerebral hemispheres with fluid-filled sacs), and porencephaly. Affected newborns may be stillborn, born with severe deformities, or present as weak, non-viable offspring.

Diagnosis, Surveillance, and Control

Diagnosis of SBV infection relies on serological and molecular methods. Serological tests, such as enzyme-linked immunosorbent assay (ELISA), detect IgM and IgG antibodies against SBV proteins (primarily N and Gn/Gc), with IgM positivity indicating acute infection. Molecular methods, including reverse transcription-polymerase chain reaction (RT-PCR) and quantitative RT-PCR (qRT-PCR), detect viral RNA in clinical samples (e.g., blood, fetal tissues, cerebrospinal fluid) and are highly sensitive for early diagnosis and confirmation of infection. Virus isolation is possible but technically challenging and not routinely used in clinical settings. Surveillance of SBV focuses on monitoring Culicoides midge populations for viral carriage and tracking reproductive failures in ruminant herds in endemic regions. SBV is primarily transmitted by Culicoides midges of the Obsoletus complex, with no direct animal-to-animal or human-to-human transmission reported. Control strategies include vector control measures (e.g., insecticides, habitat modification) to reduce midge populations, vaccination of ruminants (especially pregnant animals) with commercially available inactivated vaccines, and biosecurity measures to prevent the introduction of infected animals into non-endemic regions. Existing vaccines are effective but have limitations, including the inability to distinguish between vaccinated and infected animals, driving the development of next-generation vaccines such as recombinant protein and mRNA-based platforms.

Schmallenberg Virus Antigens